Identification of Serum Amyloid a Protein as a Potentially Useful Biomarker for Nasopharyngeal Carcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-0377
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

BMI-1 Autoantibody in Serum as a New Potential Biomarker of Nasopharyngeal Carcinoma

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2008English

Predictive Value of miR-9 as a Potential Biomarker for Nasopharyngeal Carcinoma Metastasis

British Journal of Cancer
Cancer ResearchOncology
2013English

Amyloid a as a Biomarker for Preeclampsia

Evidence Based Women's Health Journal
2020English

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Identification of Three Isoform Patterns of Human Serum Amyloid a Protein

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1988English

Serum Amyloid a (SAA): A Novel Biomarker for Uterine Serous Papillary Cancer

British Journal of Cancer
Cancer ResearchOncology
2009English

MRI-based Radiomics Signature Is a Quantitative Prognostic Biomarker for Nasopharyngeal Carcinoma

Scientific Reports
Multidisciplinary
2019English

Identification of Citrullinated Histone H3 as a Potential Serum Protein Biomarker in a Lethal Model of Lipopolysaccharide-Induced Shock

Surgery
Surgery
2011English

Serum Osteoprotegerin as a Biomarker for Vascular Disease

American Journal of Cardiology
Cardiovascular MedicineCardiology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy